1298031-94-3

Usage

Uses

Used in Medicinal Chemistry:
8-bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine is used as a compound with potential biological activity for [application reason] in medicinal chemistry. It may act as an agonist or antagonist of specific receptors, making it a valuable tool for research in pharmacology.
Used in Drug Development:
In drug development, 8-bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine is used as a precursor for the synthesis of other functionalized compounds with diverse properties and applications. Its unique structure allows for the creation of new compounds that can be explored for their therapeutic potential.
Further research on 8-bromo-6-chloro-2-methylimidazo[1,2-b]pyridazine is necessary to fully understand its potential uses and effects in various fields.

Upstream product

• 446273-59-2 4-bromo-6-chloro-3-pyridazineamine 
• 78-95-5 chloroacetone 
• 598-31-2 1-bromoacetone 

Relevant academic research and scientific papers

COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted bicyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.

IMIDAZOPYRIDAZINE DERIVATIVES AS ΡΙ3Κβ INHIBITORS

The present invention relates to substituted imidazopyridazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pΙ3Κβ inhibitors. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS

The present invention relates to novel imidazo[1,2-b]pyridazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.

IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS

The present invention relates to novel imidazo[1,2-b]pyridazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.